{
  "id": 4722049,
  "title": "White House unveils next round of MFN pricing deals with 9 midsized drugmakers",
  "url": "https://urgent.news/2026/08/31/white-house-unveils-next-round-of-mfn-pricing-deals-with-9-midsized",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-31T19:59:39.000Z",
  "source": {
    "name": "Fierce Healthcare",
    "slug": "fierce-healthcare",
    "url": "https://www.fiercehealthcare.com/pharma/white-house-unveils-next-round-mfn-pricing-deals-9-midsized-drugmakers"
  },
  "original_language": "en",
  "account": null,
  "summary": "Some four months after the White House inked the last of its expected drug pricing deals with 17 of the industry’s top players, the U.S. government is back for round 2, this time lining up agreements with a host of medium-sized biopharmas under President Trump’s ‘most favored nation’ agenda.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}